FDA NDC Directory · JSON-LD · Markdown

Phesgo

NDC 50242-245 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namepertuzumab, trastuzumab, and hyaluronidase-zzxf
Labeler / ManufacturerGenentech, Inc.
Marketing categoryBiologic License Application · App BLA761170
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsHYALURONIDASE (HUMAN RECOMBINANT) (30000 U/15mL)
PERTUZUMAB (1200 mg/15mL)
TRASTUZUMAB (600 mg/15mL)
Marketing started20200629
Package count2

External sources

Source: openFDA. Public-domain (CC0).